Skip to search formSkip to main contentSkip to account menu

GRL 98065

Known as: GRL-98065, GRL98065 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Indirect anodic oxidation applied for treatment of simulated wastewater containing Cationic Red X-GRL and Disperse Red 3B
The treatment of simulated wastewater containing Cationic Red X-GRL (X-GRL) or Disperse Red 3B (DR-3B) dye was carried out by… 
Highly Cited
2012
Highly Cited
2012
Origin of decrease in potency of darunavir and two related antiviral inhibitors against HIV-2 compared to HIV-1 protease.
Acquired immune deficiency syndrome (AIDS) is caused by the human immunodeficiency virus (HIV) type 1 and 2 (HIV-1 and HIV-2… 
2010
2010
Some insights into mechanism for binding and drug resistance of wild type and I50V V82A and I84V mutations in HIV-1 protease with GRL-98065 inhibitor from molecular dynamic simulations.
2007
2007
Potent new antiviral compound shows similar inhibition and structural interactions with drug resistant mutants and wild type HIV-1 protease.
The potent new antiviral inhibitor GRL-98065 (1) of HIV-1 protease (PR) has been studied with PR variants containing the single… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)